This systematic review is an update of our previous review published in 2017 where we looked at evidence related to glycemic control (stringent, not stringent, poor) and/or DM treatment (insulin with or without OHAs, OHAs only) on TB treatment outcomes among people with TB-DM [20]. This evidence concerns the gene INS and tuberculosis.